KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amgen (AMGN) Net Margin (2016 - 2025)

Historic Net Margin for Amgen (AMGN) over the last 17 years, with Q4 2025 value amounting to 13.51%.

  • Amgen's Net Margin rose 66100.0% to 13.51% in Q4 2025 from the same period last year, while for Dec 2025 it was 20.98%, marking a year-over-year increase of 87500.0%. This contributed to the annual value of 20.98% for FY2025, which is 87500.0% up from last year.
  • Amgen's Net Margin amounted to 13.51% in Q4 2025, which was up 66100.0% from 33.65% recorded in Q3 2025.
  • In the past 5 years, Amgen's Net Margin registered a high of 46.54% during Q1 2023, and its lowest value of 1.52% during Q1 2024.
  • Over the past 5 years, Amgen's median Net Margin value was 22.43% (recorded in 2022), while the average stood at 21.13%.
  • Its Net Margin has fluctuated over the past 5 years, first skyrocketed by 228700bps in 2023, then tumbled by -480500bps in 2024.
  • Over the past 5 years, Amgen's Net Margin (Quarter) stood at 27.74% in 2021, then fell by -15bps to 23.63% in 2022, then tumbled by -60bps to 9.36% in 2023, then fell by -26bps to 6.9% in 2024, then skyrocketed by 96bps to 13.51% in 2025.
  • Its last three reported values are 13.51% in Q4 2025, 33.65% for Q3 2025, and 15.6% during Q2 2025.